Literature DB >> 3889056

Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect.

P Cavallo-Perin, M Cassader, C Bozzo, A Bruno, P Nuccio, A M Dall'Omo, M Marucci, G Pagano.   

Abstract

Insulin resistance in liver cirrhosis may depend on either reduced sensitivity (receptor defect) and/or reduced response to insulin (postreceptor defect). To clarify the mechanism of such resistance, a [3H]glucose infusion (0.2 microCi/min) was performed for 120 min before and during a euglycemic clamp at approximately 100, 1,000, and 10,000 microU/ml steady state plasma insulin concentration in 18 compensated cirrhotics with portal hypertension and impaired glucose tolerance, and 18 healthy volunteers with no family history of diabetes, matched for sex, age, and weight. Mean fasting plasma insulin (29.2 +/- 3.4 SEM vs. 14.8 +/- 1.1 microU/ml) was significantly higher (P less than 0.001) in cirrhotics, while fasting plasma glucose was much the same in the two groups. Glucose use (milligrams per kilogram per minute) was significantly lower in cirrhotics at all three steady state plasma insulin levels: 3.04 +/- 0.34 vs. 7.72 +/- 0.61 (P less than 0.001) at approximately 100; 6.05 +/- 1.07 vs. 11.45 +/- 1.24 (P less than 0.001) at approximately 1,000; and 11.69 +/- 0.69 vs. 14.13 +/- 0.74 (P less than 0.05) at approximately 10,000 microU/ml. Mean plasma C-peptide was significantly higher in cirrhotics both basally and during the steady states (P less than 0.001); it was completely suppressed at approximately 10,000 microU/ml in controls and only 57.5% of the baseline in cirrhotics. Endogenous glucose production (milligrams per kilogram per minute) was much the same in the two groups in the fasting state and almost entirely suppressed in the controls (0.10 +/- 0.05 vs. 0.48 +/- 0.11, P less than 0.001) at approximately 100 microU/ml; at approximately 1,000 microU/ml a residual glucose production, 0.07 +/- 0.05, was observed in the cirrhotics only. In addition, insulin binding and 3-ortho-methyl-glucose transport were studied in vitro in six cirrhotics and six controls. Insulin binding to circulating monocytes and isolated adipocytes was significantly lower (P less than 0.025) in cirrhotics in all insulin concentration studies. Glucose transport values on isolated adipocytes were significantly lower in cirrhotics both basally (P less than 0.001) and at maximal insulin concentration (P less than 0.05). These results suggest that insulin resistance in human cirrhosis is more dependent on depressed peripheral glucose use than on increased endogenous glucose production, and that a combined receptor and postreceptor defect in insulin action on target cells seems to be present.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3889056      PMCID: PMC425508          DOI: 10.1172/JCI111873

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  GLUCOSE TOLERANCE AND HEPATIC DAMAGE.

Authors:  F A Coller; F L Troost
Journal:  Ann Surg       Date:  1929-10       Impact factor: 12.969

2.  Insulin-stimulated glucose transport in human adipocytes.

Authors:  T P Ciaraldi; O G Kolterman; J A Siegel; J M Olefsky
Journal:  Am J Physiol       Date:  1979-06

3.  Decreased insulin production, elevated growth hormone levels, and glucose intolerance in liver disease.

Authors:  A Hernandez; E Zorrilla; H Gershberg
Journal:  J Lab Clin Med       Date:  1969-01

4.  Insulin resistance in humans.

Authors:  J M Olefsky
Journal:  Gastroenterology       Date:  1982-12       Impact factor: 22.682

5.  C-peptide metabolism and the liver.

Authors:  C Kühl; O K Faber; P Hornnes; S L Jensen
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

Review 6.  Insulin action and the regulation of hexose transport.

Authors:  M P Czech
Journal:  Diabetes       Date:  1980-05       Impact factor: 9.461

7.  Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon.

Authors:  R S Sherwin; M Fisher; J Bessoff; N Snyder; R Hendler; H O Conn; P Felig
Journal:  Gastroenterology       Date:  1978-06       Impact factor: 22.682

8.  Degradation and secretion of insulin in hepatic cirrhosis.

Authors:  Y Iwasaki; A Ohkubo; H Kajinuma; Y Akanuma; K Kosaka
Journal:  J Clin Endocrinol Metab       Date:  1978-10       Impact factor: 5.958

9.  Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?

Authors:  D G Johnson; K G Alberti; O K Faber; C Binder
Journal:  Lancet       Date:  1977-01-01       Impact factor: 79.321

10.  Insulin resistance and insulin receptors in hepatic cirrhosis.

Authors:  A T Blei; D C Robbins; E Drobny; G Baumann; A H Rubenstein
Journal:  Gastroenterology       Date:  1982-12       Impact factor: 22.682

View more
  25 in total

1.  Regulation of glucose homeostasis in humans with denervated livers.

Authors:  G Perseghin; E Regalia; A Battezzati; S Vergani; A Pulvirenti; I Terruzzi; D Baratti; F Bozzetti; V Mazzaferro; L Luzi
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Metabolic effects of liver transplantation in cirrhotic patients.

Authors:  L Luzi; G Perseghin; E Regalia; L P Sereni; A Battezzati; D Baratti; E Bianchi; I Terruzzi; H Hilden; L C Groop; A Pulvirenti; M R Taskinen; L Gennari; V Mazzaferro
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

Review 3.  Insulin resistance in non-insulin-dependent diabetes mellitus. A review.

Authors:  A A Alzaid
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

4.  Effects of collateral vessel occlusion on oral glucose tolerance test in liver cirrhosis.

Authors:  N Tanabe; M Ishii; Y Sato; T Akahane; N Kobayashi; H Gama; T Iwasaki; T Toyota
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

5.  Insulin binding to monocytes and in vivo peripheral insulin sensitivity are normal in Graves' disease.

Authors:  P Cavallo-Perin; A Bruno; C Bozzo; L Boine; P Estivi; V Martina; G Gallone; G Pagano
Journal:  J Endocrinol Invest       Date:  1988-12       Impact factor: 4.256

Review 6.  Metabolism of energy-yielding substrates in patients with liver cirrhosis.

Authors:  M J Müller; K H Böker; O Selberg
Journal:  Clin Investig       Date:  1994-08

7.  Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.

Authors:  E Bugianesi; A Gastaldelli; E Vanni; R Gambino; M Cassader; S Baldi; V Ponti; G Pagano; E Ferrannini; M Rizzetto
Journal:  Diabetologia       Date:  2005-03-04       Impact factor: 10.122

8.  Exercise and physical activity in cirrhosis: opportunities or perils.

Authors:  Annette Bellar; Nicole Welch; Srinivasan Dasarathy
Journal:  J Appl Physiol (1985)       Date:  2020-04-02

9.  Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism.

Authors:  O Selberg; W Burchert; J vd Hoff; G J Meyer; H Hundeshagen; E Radoch; H J Balks; M J Müller
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

10.  In vivo insulin action in hepatocellular and cholestatic liver cirrhosis.

Authors:  N Barzilai; P Cohen; E Karnieli; R Enat; O Epstein; J Owen; N McIntyre
Journal:  J Endocrinol Invest       Date:  1991-10       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.